Inhaled drug may prevent lung cancer: study

	Tweet

A drug approved to treat a range of conditions may also work to prevent lung cancer in people who have given up smoking, U.S. researchers reported on Tuesday.

The drug, called iloprost, is approved in inhaled forms to treat pulmonary hypertension, when blood pools near the lungs, a connective tissue disease called scleroderma and a nerve condition called Raynaud’s phenomenon.

Dr. Robert Keith of the Denver Veterans Affairs Medical Center and colleagues tested an oral version to see if it might prevent lung cancer in smokers and former smokers.

"Oral iloprost showed promise for preventing lung cancer in former, but not current, smokers in a phase II clinical trial,” they wrote in a summary presented to a meeting of the American Thoracic Society in New Orleans.

Iloprost is a version of prostacyclin, a drug in the prostaglandin class that prevents lung cancer in mice.

Keith, who has been testing several drugs to prevent lung cancer, looked at biopsies taken from the lungs of 125 current and former smokers.

They treated half with placebo and half with iloprost, and then performed bronchoscopy examinations to assess precancerous changes in the lungs.

Six months later, “former smokers showed significant improvements on all measures, indicating that treatment with iloprost may reduce the risk of developing lung cancer among former smokers,” the researchers said.

“Interestingly, current smokers did not show any significant improvements,” they added.

“Oral iloprost significantly improves endobronchial dysplasia in former smokers and deserves further study to determine if it can prevent the development of lung cancer.”

Swiss drug maker Actelion markets inhaled iloprost under the brand name Ventavis.

It is also sold in an intravenous form under the trade name Ilomedin by Schering, acquired by Merck.

In April, researchers said a natural supplement derived from food, called myo-inositol, seems to stop the precancerous changes that lead to lung cancer.

Cigarette smoke causes 90 percent of all cases of lung cancer, which kills 1.2 million people a year globally. But only about 10 percent of smokers ever develop lung cancer, although they often die of other causes like heart disease, stroke or emphysema.

---
WASHINGTON (Reuters)

RELATED STORIES:
New lung cancer drug shows dramatic results for shrinking tumors   Lung cancer slowed by Pfizer drug   Carotenoid supplements tied to lung cancer risk   Genetic variations raise lung cancer risk for smokers and ex-smokers   New radiation therapy could help in lung cancer   Positive CT scan for lung cancer may resolve   Advances in lung cancer research announced at conference   Heavy marijuana use not linked to lung cancer   Plant product may help prevent lung cancer   Blood test may find early lung cancer: study   Gene found that may predict lung cancer in smokers   Nutrients may be why some smokers avoid cancer   Asian lung cancer patient survival exceeds Caucasians’ on multiple regimens   New Test Promises Quicker, More Accurate Evaluation for Cystic Fibrosis Patients   A new way to look at lung cancer and tobacco carcinogens   Learn the Signs and Symptoms of Lung Cancer   Genetic mutation associated with increased risk of lung cancer   UT Southwestern research uncovers genetic link between emphysema, lung cancer   New lung cancer test predicts survival   Gene Panel Predicts Lung Cancer Survival   Gene Expression Profiling Not Quite Perfected in Predicting Lung Cancer Prognosis   Inhaler treatment for lung cancer

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]